Correlation between serum urea nitrogen, cystatin C, homocysteine, and chronic heart failure

Zongqin Yao1, Guangfeng Li2, Guangcai Li3

  • 1Department of Cardiology, Linyi Central Hospital Linyi, Shandong Province, China.

Insights

Elevated uric acid (UA), cystatin C (Cys-C), and homocysteine (Hcy) levels are linked to chronic heart failure (CHF). These markers show potential for early CHF screening and clinical evaluation.

Area of Science:

  • Biochemistry
  • Cardiology
  • Clinical Diagnostics

Background:

  • Chronic heart failure (CHF) is a complex clinical syndrome.
  • Biomarkers for early detection and risk stratification in CHF are crucial.

Purpose of the Study:

  • To investigate the correlation between serum uric acid (UA), cystatin C (Cys-C), and homocysteine (Hcy) levels and chronic heart failure (CHF).
  • To assess the utility of these biomarkers in evaluating CHF severity and outcomes.

Main Methods:

  • A case-control study involving 45 CHF patients and 45 healthy controls.
  • Measurement of serum UA, Cys-C, and Hcy levels in all participants.
  • Correlation analysis with clinical parameters including cardiac function classification, major adverse cardiovascular events (MACE), left ventricular end-diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), and New York Heart Association (NYHA) grade.

Main Results:

  • CHF patients exhibited significantly higher serum UA, Cys-C, and Hcy levels compared to controls (P<0.05).
  • These biomarker levels increased with worsening cardiac function classification and were higher in patients with MACE.
  • Positive correlations were observed between UA, Cys-C, Hcy and LVEDD and NYHA grade, and negative correlations with LVEF (P<0.05).
  • Combined diagnostic sensitivity for CHF was higher than individual markers, though specificity was lower.

Conclusions:

  • Serum UA, Cys-C, and Hcy levels are elevated in CHF patients.
  • These biomarkers may serve as valuable reference indexes for the clinical screening of early CHF.
  • They offer potential for clinical evaluation and risk stratification in patients with chronic heart failure.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
287
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
167
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
45
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
233
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
167
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
307